SCHEMBL23097286

SCHEMBL23097286

c1ccc(-n2c(-c3ccc4c5ccccc5n(-c5ccc(-c6ccc(-n7c8ccccc8c8ccc(-c9nc%10ccccc%10n9-c9ccccc9)cc87)cc6)cc5)c4c3)nc3ccccc32)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.58
ESR2 Q92731 1/20 0.58
GRIA1 P42261 1/20 0.53
CACNG8 Q8WXS5 1/20 0.53
CACNG2 Q9Y698 1/20 0.53
KDM4E B2RXH2 2/20 0.49
ATM Q13315 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
PTGER4 P35408 1/20 0.48
HDAC1 Q13547 1/20 0.48
HDAC8 Q9BY41 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48
PTGS2 P35354 1/20 0.48
KMT2A Q03164 3/20 0.48
MEN1 O00255 2/20 0.48
HSP90AA1 P07900 1/20 0.48
MAPT P10636 1/20 0.48
HTT P42858 2/20 0.48
MAPK1 P28482 1/20 0.48
ALDH1A1 P00352 8/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21890270 0.97 ESR1 (0.57) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL19238820 0.96 ESR1 (0.56) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL10047619 0.94 ESR1 (0.64) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL347643 0.94 ESR1 (0.64) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL12205094 0.94 ESR1 (0.64) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL10055038 0.94 ESR1 (0.64) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL13314068 0.93 ESR1 (0.66) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL19238817 0.92 ESR1 (0.56) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL15930295 0.92 ESR1 (0.58) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL12741598 0.91 ESR1 (0.57) ESR1ESR2GRIA1CACNG8CACNG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3792259-B1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME CHANGCHUN HYPERIONS TECH CO LTD (CN) 2023-11-29 EP disclosed
US-20210078989-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME CHANGCHUN HYPERIONS TECHNOLOGY CO., LTD (CN) 2021-03-18 US disclosed
EP-3792259-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME Changchun Hyperions Technology Co., Ltd. (CN) 2021-03-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210078989-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME SOX18, TYR, L1CAM ESR1 65/4885ESR2 849/4885GRIA1 751/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.